triiodothyronine has been researched along with methotrexate in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (25.00) | 18.7374 |
| 1990's | 2 (10.00) | 18.2507 |
| 2000's | 6 (30.00) | 29.6817 |
| 2010's | 7 (35.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, T; Adachi, H; Asano, N; Date, F; Fujiwara, K; Iinuma, K; Ito, S; Kakyo, M; Kondo, TN; Kondo, Y; Matsuno, S; Nagura, H; Nakagomi, R; Nishio, T; Nunoki, K; Ohtani, H; Okabe, M; Ono, K; Onogawa, T; Sato, E; Seki, M; Shiiba, K; Shimosegawa, T; Sugita, J; Suzuki, M; Suzuki, T; Tanemoto, M; Tokui, T; Unno, M | 1 |
| Abe, T; Inui, K; Masuda, S; Saito, H; Takeuchi, A | 1 |
| Folkers, G; Hagenbuch, B; Klenk, U; Meier, PJ; Pizzagalli, F; Stieger, B | 1 |
| Hori, S; Kikkawa, T; Mori, S; Ohtsuki, S; Otagiri, M; Takanaga, H; Terasaki, T | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Fent, K; Popovic, M; Smital, T; Zaja, R | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Graze, PR; Haskell, CM; Korenman, SG; Sparks, FC | 1 |
| Akyar, S; Baskal, N; Dagci, SS; Ekinci, C; Erdogan, G; Kamel, AN | 1 |
| Bessho, F | 1 |
| Owens, AH; Rivlin, RS; Sokoloff, L | 1 |
| Hershman, JM; Melmed, S; Park, J | 1 |
| Foley, JF; Kessinger, MA; Lemon, HM | 1 |
| Bock, ME; Cattini, PA; Nachtigal, MW; Nickel, BE | 1 |
| Fleck, C; Hilger, R; Jurkutat, S; Karge, E; Merkel, U; Schimske, A; Schubert, J | 1 |
| Hsieh, TY; Hsu, KF; Huang, SC; Kuo, PL | 1 |
2 review(s) available for triiodothyronine and methotrexate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Localized non-Hodgkin's lymphoma of the adrenal and thyroid glands.
Topics: Addison Disease; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocorticotropic Hormone; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bleomycin; Cyclophosphamide; Dexamethasone; Fludrocortisone; Goiter, Nodular; Humans; Hydrocortisone; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoxantrone; Thyroid Gland; Thyroid Neoplasms; Thyrotropin; Thyroxine; Tomography, X-Ray Computed; Triiodothyronine; Ultrasonography; Vincristine | 1992 |
1 trial(s) available for triiodothyronine and methotrexate
| Article | Year |
|---|---|
Treatment of breast cancer with oral four-drug chemotherapy.
Topics: Administration, Oral; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Prednisone; Prognosis; Triiodothyronine | 1980 |
17 other study(ies) available for triiodothyronine and methotrexate
| Article | Year |
|---|---|
LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers.
Topics: Amino Acid Sequence; Animals; Anion Transport Proteins; Antimetabolites, Antineoplastic; Carrier Proteins; Gastrointestinal Neoplasms; Humans; Immunohistochemistry; Liver; Methotrexate; Molecular Sequence Data; Xenopus laevis | 2001 |
Multispecific substrate recognition of kidney-specific organic anion transporters OAT-K1 and OAT-K2.
Topics: Animals; Carrier Proteins; Cattle; Cell Line; Cells, Cultured; Folic Acid Antagonists; Kidney; Kinetics; Membrane Proteins; Methotrexate; Multidrug Resistance-Associated Proteins; Oocytes; Organ Specificity; Organic Anion Transporters; Substrate Specificity; Transfection; Xenopus laevis | 2001 |
Identification of a novel human organic anion transporting polypeptide as a high affinity thyroxine transporter.
Topics: Amino Acid Sequence; Animals; Brain; CHO Cells; Chromosomes, Human, Pair 12; Cloning, Molecular; Cricetinae; Diiodothyronines; Estradiol; Estrone; Female; Humans; Leydig Cells; Male; Membrane Proteins; Molecular Sequence Data; Oocytes; Organ Specificity; Organic Anion Transporters; Sequence Homology, Amino Acid; Sulfobromophthalein; Testis; Thyroxine; Triiodothyronine; Xenopus | 2002 |
Mouse reduced in osteosclerosis transporter functions as an organic anion transporter 3 and is localized at abluminal membrane of blood-brain barrier.
Topics: Animals; Biological Transport; Blood-Brain Barrier; Capillaries; Disease Models, Animal; Estrone; Male; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Osteosclerosis; Penicillin G; RNA, Messenger | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Molecular characterization of zebrafish Oatp1d1 (Slco1d1), a novel organic anion-transporting polypeptide.
Topics: Animals; Evolution, Molecular; Glycosylation; Gonadal Steroid Hormones; HEK293 Cells; Humans; Ion Transport; Organic Anion Transporters; Protein Multimerization; Zebrafish; Zebrafish Proteins | 2013 |
Systemic therapy for metastatic breast cancer.
Topics: BCG Vaccine; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Estrogens; Female; Fluorouracil; Humans; Immunotherapy; Mastectomy; Methotrexate; Neoplasm Metastasis; Prednisone; Propionibacterium acnes; Receptors, Estrogen; Triiodothyronine | 1977 |
[Organ dysfunctions caused by cancer therapy in children].
Topics: Antineoplastic Agents; Bone Development; Child; Child, Preschool; Cyclophosphamide; Female; Growth Disorders; Heart; Humans; Infant; Leukemia, Lymphoid; Male; Methotrexate; Radiotherapy Dosage; Skull; Thyroid Gland; Thyrotropin; Thyroxine; Triiodothyronine | 1985 |
Inhibition by methotrexate of triiodothyronnine stimulation of oxygen consumption in man.
Topics: Humans; Male; Methotrexate; Middle Aged; Oxygen Consumption; Triiodothyronine | 1965 |
Triiodothyronine induces a transferable factor which suppresses TSH secretion in cultured mouse thyrotropic tumor cells.
Topics: Animals; Cells, Cultured; Cycloheximide; Dactinomycin; Female; In Vitro Techniques; Methotrexate; Mice; Neoplasms, Experimental; Thyroid Neoplasms; Thyrotropin; Thyrotropin-Releasing Hormone; Triiodothyronine | 1981 |
Differential expression of human placental growth hormone variant and chorionic somatomammotropin genes in choriocarcinoma cells treated with methotrexate.
Topics: Actins; Base Sequence; Choriocarcinoma; Chorionic Gonadotropin; DNA Probes; Female; Gene Expression; Growth Hormone; Humans; Methotrexate; Molecular Sequence Data; Placental Hormones; Placental Lactogen; Pregnancy; RNA, Messenger; Triiodothyronine; Tumor Cells, Cultured; Uterine Neoplasms | 1993 |
Ex vivo stimulation of renal transport of the cytostatic drugs methotrexate, cisplatin, topotecan (Hycamtin) and raltitrexed (Tomudex) by dexamethasone, T3 and EGF in intact human and rat kidney tissue and in human renal cell carcinoma.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Biological Transport; Carcinoma, Renal Cell; Cisplatin; Dexamethasone; Epidermal Growth Factor; Female; Glucocorticoids; Humans; Kidney; Kidney Neoplasms; Methotrexate; Quinazolines; Rats; Rats, Wistar; Thiophenes; Topotecan; Triiodothyronine | 2002 |
Uterine choriocarcinoma accompanied by an extremely high human chorionic gonadotropin level and thyrotoxicosis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Thyrotoxicosis; Triiodothyronine; Uterine Neoplasms; Vincristine | 2008 |